DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial

BACKGROUND: Children are susceptible to severe influenza infections and facilitate community transmission. One potential strategy to improve vaccine immunogenicity in children against seasonal influenza involves a trivalent hemagglutinin DNA prime-trivalent inactivated influenza vaccine (IIV3) boost...

Descripción completa

Detalles Bibliográficos
Autores principales: Houser, Katherine V., Yamshchikov, Galina V., Bellamy, Abbie R., May, Jeanine, Enama, Mary E., Sarwar, Uzma, Larkin, Brenda, Bailer, Robert T., Koup, Richard, Paskel, Myeisha, Subbarao, Kanta, Anderson, Edwin, Bernstein, David I., Creech, Buddy, Keyserling, Harry, Spearman, Paul, Wright, Peter F., Graham, Barney S., Ledgerwood, Julie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214651/
https://www.ncbi.nlm.nih.gov/pubmed/30388160
http://dx.doi.org/10.1371/journal.pone.0206837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214651/
https://www.ncbi.nlm.nih.gov/pubmed/30388160
http://dx.doi.org/10.1371/journal.pone.0206837

Ejemplares similares